Since the beginning of November, Peter Kolchinsky‘s RA Capital Management has informed the U.S. Securities and Exchange Commission that it’s increased its positions in two of its holdings: Dynavax ...
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky’s RA Capital. If you want to skip our introduction and take a look at the top five stocks in ...
RA Capital released its latest quarterly 13F fund update with the SEC last week, showcasing new positions in the multi-stage healthcare and life science-focused fund. The Boston-based fund has emerged ...
Peter Kolchinsky-led RA Capital’s New Positions Feature CureVac, Mineralys, Pilant, Enliven Therapeu
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. RA Capital released its latest quarterly 13F fund update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results